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We report 13 cases of ophthalmic complications result-
ing from dengue infection in Singapore. We performed a
retrospective analysis of a series of 13 patients with
dengue fever who had visual impairment. Investigations
included Humphrey automated visual field analyzer, Amsler
charting, fundus fluorescein angiography, and optical
coherence tomography. Twenty-two eyes of 13 patients
were affected. The mean age of patients was 31.7 years.
Visual acuity varied from 20/25 to counting fingers only.
Twelve patients (92.3%) noted central vision impairment.
Onset of visual impairment coincided with the nadir of
serum thrombocytopenia. Ophthalmologic findings include
macular edema and blot hemorrhages (10), cotton wool
spots (1), retinal vasculitis (4), exudative retinal detach-
ment (2), and anterior uveitis (1). All patients recovered
visual acuity to 20/30 or better with residual central sco-
toma by 12 weeks. These new complications suggest a
widening spectrum of ophthalmic complications in dengue
infection. 
D
engue fever (DF) is the most prevalent form of fla-
vivirus infection in humans. Borne by the Aedes mos-
quito, the infection is endemic in the tropics and warm
temperate regions of the world. The highest incidence
occurs in Southeast Asia, India, and the American tropics.
Worldwide cases of illness exceed100 million per year
(1,2). 
Dengue hemorrhagic fever (DHF) is a severe and
potentially fatal form of the disease. Twenty-five thousand
deaths are reported annually to the World Health
Organization (WHO). The annual incidence now exceeds
500,000 cases annually and is still rising, despite environ-
mental controls (3). DHF is strongly related to previous
sensitization of heterologous dengue infection. Increasing
endemicity and co-circulation of different serotypes is
therefore necessary for the increase in incidence of DHF.
DF is characterized by an abrupt onset of fever after a
2- to 7-day incubation period, with temperatures reaching
41°C. Other symptoms include severe malaise, headaches,
and retroorbital and lumbrosacral pain. Patients also expe-
rience respiratory symptoms (sore throat, rhinitis, and
cough), nausea, anorexia, and altered taste sensation. A
transient macular rash is often seen on day 1 to day 2 of ill-
ness. This rash disappears, but a second, maculopapular
rash appears on days 3–6 of illness. The secondary rash
coincides with defervescence and typically involves the
trunks, limbs, and face; palms and soles are spared. Blood
dyscrasias include thrombocytopenia and neutropenia
(leukopenia). The illness is usually self-limiting with min-
imal systemic sequelae, but it may require prolonged con-
valescence lasting several weeks.
DHF is defined by WHO as DF associated with throm-
bocytopenia (<100 × 109 cells/L) and hemoconcentration
(hematocrit >20% above baseline). Its most severe form,
dengue shock syndrome (DSS), is associated with
hypotension, narrowing of pulse pressure (<20 mm Hg),
and circulatory failure in 30% of cases. The early phase of
DHF is indistinguishable from DF. The death rate for
untreated DHF/DSS can be as high as 10%–15% in places
where emergency supportive treatment with intravenous
fluids and platelet replacement is not readily accessible
(4).
Ophthalmic complications associated with DF and
DHF have not been classically described. Within the oph-
thalmic community, this complication is being observed
more frequently in recent times. However, only a few iso-
lated case reports have been published (5–13). These
reports attribute ocular complications to the transient
thrombocytopenia and resulting bleeding diathesis. The
course of the eye manifestations has also not been well-
described. We report a series of 13 patients who had oph-
thalmic symptoms after DF or DHF, and describe the
course, spectrum of manifestations, and prognosis and
treatment of these new and emergent complications. 
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We describe a retrospective observational case series of
13 patients who were seen at The Eye Institute (Singapore)
over 6 months from September 2004 to February 2005.
Patient follow-up varied from 2 weeks to 5 months.
Diagnosis was made by a referring infectious disease
physician on the basis of characteristic clinical signs and
symptoms and confirmed on dengue polymerase chain
reaction (PCR), dengue serology (immunoglobulin M
[IgM] and IgG seroconversion), or both.
Real-time automated reverse transcriptase (RT)-PCR
assay was conducted with the Dengue LC RealArt RT-
PCR Kit on the Light Cycler (Roche Diagnostics,
Mannheim, Germany) in patients with <5 days of fever. In
patients with pyrexia in excess of 5 days, serologic studies
were conducted with the PanBio (Sinnamon Park,
Queensland, Australia) Dengue Duo IgM and IgG Rapid
Strip Test. Classification of DF and DHF was made on the
basis of WHO guidelines.
Patients were referred to The Eye Institute following
complaints of visual symptoms. All patients had visual
acuity measured with a Snellen acuity chart. All underwent
a full slit-lamp anterior segment examination as well as
dilated fundi examination with slit-lamp biomicroscopy.
Upon clinical diagnosis, patients underwent further testing
of visual fields (Humphrey automated visual field analyz-
er [HVF], Amsler charting, and fundal fluorescein angiog-
raphy [FA]), and measurement of central macular
thickness with optical coherence tomography (OCT3,
Zeiss, Göttingen, Germany). 
Patients were followed up by examination of serial
platelet counts until at least 2 consecutive counts showed
an upward trend. Retinal findings were documented with
serial color fundal photography. Tests (HVF, FA, and
OCT) were repeated based on clinical assessment of the
patient’s response and clinical signs of resolution.
Results
Demographics
Thirteen patients (6 male, 7 female) with ophthalmic
symptoms following DF were reviewed. Eleven patients
were Singaporeans; the other 2 were Chinese nationals. All
cases were contracted in Singapore, based on the absence
of travel history 1 month before the illness. All but 1
patient (Malay) was of Chinese race. The ages ranged from
20 to 49 years (mean 31.7 ± 7.9 years, median 31 years)
with no age differences between male and female patients.
All but 1 patient were classified as having DF (online
Appendix Figure, from http://www.cdc.gov/ncidod/EID/
vol12no02/05-0274-G_app.htm).
Symptoms
All patients complained of blurring of vision. Nine
patients described bilateral visual symptoms in both eyes;
4 (30.7%) noted unilateral visual impairment. Twenty-two
eyes from 13 patients were affected. Snellen visual acuity
varied from 20/25 to counting fingers only (median 20/40).
Seven eyes (31.8%) had vision of 20/100 or worse. Twelve
(92.3%) patients described blurring associated with a loss
of central vision (relative central scotoma) (Figure 1). This
symptom was demonstrated on Amsler charting and auto-
mated HVF testing. 
Onset of Visual Symptoms
The onset of visual symptoms closely correlated with
the nadir of thrombocytopenia associated with DF. Of the
9 patients with available daily serial serum platelet meas-
urements, all had visual symptoms within 1 day of their
lowest platelet counts. Five (55.6%) patients complained
of visual symptoms on the day of their nadir; 2 patients
exhibited this symptom 1 day after their lowest count, and
2 patients had this symptom 1 day before their lowest
count (mean 6.8 ± 0.8 days, median 7 days) (Figure 2). 
Signs
The most common ophthalmic signs were found on the
macular region of the retina (Figure 3). Macular edema
was the most common pathology; it occurred in 10
(76.9%) patients. The second most common finding on
ophthalmoscopy was macular hemorrhage (9 [69.2%]
patients). Characteristically, these took the form of blot
hemorrhages. These areas corresponded to the areas of
visual scotoma experienced by the patients. Four cases of
vasculitis occurred. One involved the macular vasculature,
and 3 patients had panretinal vasculitis. Two cases with
severe panretinal vasculitis were associated with exudative
retinal detachment. Other less common fundus findings
include perifoveal telangectasia and cotton wool spots,
both at the macula and peripheral retina. Anterior segment
findings were relatively uncommon in our series. Only 1
patient had associated anterior uveitis. 
Investigations
Diagnosis of dengue was based on a combination of
clinical findings correlated to positive results from dengue
serology, PCR, or both. Serial serum platelet measure-
ments tracked the thrombocytopenic pattern. All but 4
patients had available serial serum platelet measurements.
Three patients had their first platelet measurements only
after 1 week of visual symptoms. One patient had been
transfused before onset of visual symptoms, but even then,
when examined, her platelet count was only 5.0 × 109
cells/L. All but 1 patient was classified as having primary
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positive PCR but negative IgG serologic findings were
deemed to have primary dengue. Alternatively, patients
with dengue symptoms of >5 days’ duration who had a
positive IgG serologic finding were classified as having
secondary dengue infection.
The mean platelet nadir at the time of onset of visual
complaints was 42.8 ± 20.1 × 109 cells/L(range 5–77 × 109
cells/L, normal 160–390 × 109 cells/L). Complete blood
count showed that these findings corresponded to their
peak hematocrit of 43.0 ± 4.3% and a leukopenia nadir of
2.4 ± 1.0 × 109 cells/L(range 1.3–3.9 × 109 cells/L, normal
4–10 × 109 cells/L). All patients demonstrated central sco-
toma due to macular pathology by means of Amsler chart
reading and automated visual field (HVF) testing. Fundal
fluorescein angiography (FA) performed in 4 severe cases
demonstrated extensive fluid leakage from retinal vessels
corresponding to clinical observation of macular edema
(Figure 3B) and peripheral vasculitis. This finding was
corroborated on OCT (Figure 3C), which showed thicken-
ing of the macula.
Management and Progress of Retinopathy
All but 2 patients were treated conservatively. For these
11 patients, clinical signs resolved spontaneously and rap-
idly after they recovered from thrombocytopenia (median
3 days). Two patients with extensive panretinal vasculitis
and exudative detachment were treated with systemic
steroids. One patient was given oral prednisolone at a dose
of 1 mg/kg/day for 1 week; this dosage was tailed off slow-
ly over 2 months. The other patient received 6 hourly doses
of intravenous methylprednisolone 250 mg for 3 days, fol-
lowed by oral prednisolone at 1 mg/kg/day for 1 week,
tailed off over the next 2 months in a similar manner. None
of the patients who had steroid treatment reported adverse
effects after steroid treatment. Both patients demonstrated
visual recovery with resolution of clinical signs after 1
month. One patient with bilateral anterior uveitis was treat-
ed with topical prednisolone 1%. The anterior uveitis
resolved by day 7 with no subsequent relapse, and the
medication was tapered off (online Appendix Figure).
Outcomes and Prognosis
One patient defaulted follow-up after 2 weeks because
vision had returned to normal. The remaining 12 patients
had a recovery period between 6 days to 3 months.
Resolution of clinical signs was closely followed by
improvement of their Snellen acuity back to pre-retinopa-
thy levels. Nine patients (75%) achieved a best corrected
visual acuity of 20/25 or better (mean 4.0 weeks).
However, despite resolution of ocular signs, all reported
residual mild central scotoma that was reflected on HVF as
an area of subtle decrease in sensitivity in the central
vision (Figure 1). This persisted even up to 3 months after
complete systemic recovery.
Discussion
Dengue is the most common mosquitoborne viral dis-
ease in humans. In recent years, it has become a major
international public health concern. Globally, 2.5 billion
people live in areas where dengue viruses can be transmit-
ted (4,14–16). Over the past 25 years, the geographic
spread of both the mosquito vectors and the viruses has led
to the global resurgence of epidemic DF and emergence of
DHF; with the development of hyperendemicity in many
urban centers of the tropics. Though Southeast Asian in
origin, this study would be relevant to clinicians across
continents where dengue has taken a foothold. 
The spectrum of ophthalmologic manifestations would
lead one to conclude that several pathophysiologic
processes are involved. The first and most obvious patho-
genesis would be the thrombocytopenic state, with its
resultant bleeding tendency, which gives rise to increased
incidence of hemorrhage. These hemorrhages manifest as
retinal blot hemorrhages in the macula and retinal periph-
ery. We believe that the preponderance of cases found with
complications located at the macula in our series may be
due to the higher likelihood of awareness by the patient of
visual impairment resulting from poor central vision. The
incidence of dengue-related complications may be higher,
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Figure 1. Humphrey visual fields of patient 9 at 1 week after onset
of visual symptoms. Central scotoma of the right visual field is
denoted as black squares (red arrow).given that some patients with changes occurring exclusive-
ly in the retinal periphery may not have any perceptible
visual impairment. Macular edema and occult vascular
changes with minimal functional disturbance may also be
unreported by the patient. Clinically, these cases may even
be missed on examination alone. Investigations such as
fundus FA and OCT can help to detect these occult cases.
These signs could also lend insight to the microvascular
changes that may be occurring in the rest of the body.
However, a hypocoagulable state alone would not account
for the entire range of complications seen. The presence of
periphlebitis, anterior uveitis, and macular edema indicate
a hyperpermeable and inflammatory process. Parallels can
also be drawn from the observation that the visual symp-
toms tend to occur and manifest at or close to the moment
when the serum platelets and leukocytes levels reach their
trough, while the disease is at its peak. 
An hypothesis about the pathogenesis of DHF, though
proven true in vivo, involves immune clearance by way of
induction of cross-reactive T-cell memory, T-cell prolifer-
ation, and recognition of dengue viral antigens on infected
monocytes by sensitized CD4+CD8– and CD4–CD8+
cytotoxic T cells. This results in the release of cytokines
with vasoactive and procoagulant properties (interleukins,
tumor necrosis factor, platelet-activating factor, and uroki-
nase) (17,18). Vasoactive and inflammatory mediators
cause capillary leakage, which may form the basis for
macular edema and breakdown of the aqueous blood bar-
rier, resulting in anterior uveitis and periphlebitis. In the
series reported by Lim et al., ocular complications were
mainly confined to the maculae (5). However, in our series
the extent of involvement includes both the peripheral reti-
na in the posterior segment and the anterior segment
(anterior uveitis), which suggests a more widespread
inflammatory process in the eye.
The onset of visual symptoms occurs on or close to the
day of the lowest serum platelet level. Visual recovery, in
the form of improvement of signs and symptoms, usually
corresponds to improving platelet levels but may take sev-
eral weeks to reach a steady state. Most patients report
residual visual impairment in the form of central or para-
central scotoma. 
The use of systemic steroids in 2 patients did not appear
to aggravate the visual complications or the systemic
dengue infection. This finding is supportive of an inflam-
matory or immune-mediated pathophysiology after acute
dengue infections. Visual symptoms and visual acuity
recovered in the same manner and speed as in patients with
milder, untreated cases. However, like the other patients,
both also described a persistent central scotoma despite
normal functional Snellen visual acuities. However, we
were not able to draw any statistical conclusions on the
efficacy of treatment outcomes. 
Our findings may have arisen as a result of an increase
in incidence and awareness of DF in Singapore (19).
However, we believe that these complications may consti-
tute a change in the pathoimmunology of the disease. The
increase in inflammatory response seen in recent DF
patients may be due to a change in pathogenicity of the
virus, although any viral mutation would be speculative at
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Figure 3. Fundal photos, fundal fluorescein angiography (FA) and
optical coherence tomography (OCT) of patient 9. A) areas of blot
hemorrhages temporal to the right fovea. B) bilateral dye leakage
from the retinal veins, more severe on the right than left. C) OCT
gives a 2-dimensional graphic representation of a cross-section of
the macular region. The area marked with the red arrow marks the
site of exudative retinal detachment. Both sides have marked reti-
nal thickening (edema). Photo: Ken Thian. 




Cbest with our current understanding of the disease. Hence,
the identification of serotypes or viral RNA epitopes in
future studies might identify particular serotype or combi-
nations of serotypes, as in the case of secondary infections,
of heterologous dengue serotypes that might be found to
confer a higher risk of ocular and possibly systemic com-
plications.
This case series describes the widest variety of ocular
complications of dengue infection to date. Although the
ophthalmic community has been reporting more of such
cases in recent times, the number of cases in this series is
still relatively small and represents a limitation to the
results of this report. No attempt at randomization had
been made with regards to treatment. Management was
based on clinical judgment on the progress of pathologic
features. However, we feel that the consistency of visual
outcomes in these patients still reflects the course of
dengue-related ophthalmic complications. 
In conclusion, DF and DHF can cause ophthalmic
symptoms that were not previously well-described in the
medical literature. Blurring of vision typically coincides
with the nadir of thrombocytopenia and occurs ≈1 week
after onset of fever. Clinical features include retinal edema,
blot hemorrhages, and vasculitis. Less common features
include exudative retinal detachment, cotton wool spots,
and anterior uveitis. 
Prognosis is generally good as the disease is often self-
limiting, resolving spontaneously even without treatment.
However, patients may experience mild relative central
scotoma that may persist for months. The use of steroids in
treating this inflammatory eye condition is controversial. A
randomized controlled trial is under way to evaluate the
effect of systemic steroids on dengue retinopathy; results
will be reported in due course.
With increasing epidemicity and co-circulation of mul-
tiple dengue serotypes, the occurrence of DF and DHF is
set to rise. Similarly we expect to see an increase in this
newly emergent facet of dengue ophthalmic morbidity. A
heightened awareness of dengue-related ophthalmic com-
plications among clinicians involved in the care of patients
with dengue would facilitate prompt referral for ophthal-
mologic assessment and management.
Dr Chan is an ophthalmologist in the Department of
Ophthalmology at Tan Tock Seng Hospital, which is part of The
Eye Institute in Singapore. His research interests include the field
of medical retina and high-speed retinal angiography.
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